Partner at Invivo Partners, a venture capital firm specializing in early-stage biotech companies.
Member of the Board of Directors at OneChain and Telomere Therapeutics and Observer at Arthex, Pulmobiotics, Gyala Therapeutics, Telum, and Esobiotec.
Previously a Project Manager in the Knowledge Transfer and Innovation Unit at the Research Institute of the Vall d'Hebron Hospital (VHIR) in Barcelona.
5 years of R&D experience in oncology and gene therapy, leading to publications in peer-reviewed journals and collaborations with biotechnology companies.
BSc in Biotechnology (Autonomous University of Barcelona, UAB), PhD in Biotechnology (University of Barcelona, UB) with a Postgraduate course in Innovation Management (UAB).